Can an MS drug help preserve insulin production in type 1 diabetes?
NCT ID NCT07548996
First seen Apr 24, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study tests whether dimethyl fumarate, a drug used for multiple sclerosis, can help preserve the body's ability to produce insulin in adults with type 1 diabetes. About 96 adults aged 18-65 with recent-onset type 1 diabetes will take the drug or receive standard insulin therapy for 24 weeks, then be followed for a year. The goal is to see if the drug slows the loss of insulin-making beta cells, potentially reducing the amount of insulin needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jiangsu Provincial Hospital
RECRUITINGNanjing, Jiangsu, 210029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.